PDCD1 and primary central nervous system lymphoma: Importantly, PCNSL exhibited frequent 9p24.1/PD-L1/PD-L2 copy number alterations [9] and even PD-1 blockade demonstrated clinical activity in relapsed/refractory PCNSL [12], although only small number of patients were evaluated.